Bisphenol A: FDA Analysis Mistakes and Redesign Opportunities

Wonder how FDA concluded BPA levels in people were too low to matter? False assumptions and circular logic…

  • Where the FDA went wrong
  • Risks of using existing substitutes
  • Designing endocrine disruption out of new chemicals
More information

Author: DES Daughter

Activist, blogger and social media addict committed to shedding light on a global health scandal and dedicated to raise DES awareness.

Have your say! Share your views

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: